Telfast/Telfast Oral Suspension Dosage/Direction for Use

Film-coated tablet: Posology: Adults: The recommended dose of fexofenadine hydrochloride for adults is 120 mg once daily or 180 mg once daily taken before a meal.
Fexofenadine is a pharmacologically active metabolite of terfenadine.
Paediatric population: Children aged 12 years and over: The recommended dose of fexofenadine hydrochloride for children aged 12 years and over is 120 mg once daily or 180 mg once daily taken before a meal.
Children under 12 years of age: The efficacy and safety of fexofenadine hydrochloride 120 mg or 180 mg has not been studied in children under 12.
Special populations: Studies in special risk groups (older people, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.
Oral suspension: Adults and Children aged 12 years or older: Allergic Rhinitis: 10 mL (60 mg) twice daily, when required.
Seasonal Allergic Rhinitis: 20 mL (120 mg) or 30 mL (180 mg) once daily, when required.
Urticaria: 30 mL (180 mg) once daily, when required.
Pediatrics: Allergic Rhinitis and Seasonal Allergic Rhinitis: Children aged 2 to 11 years: 5 mL (30 mg) twice daily, when required.
Urticaria: Children aged 6 to 11 years: 5 mL (30 mg) twice daily, when required.
Dosage adjustment is not required in the elderly or in patients with hepatic or renal impairment.